The biotechnology company Oxolife returns to its founders: Agnès Arbat and Ignasi Canals have regained the license of their product OXO-001, a patented drug for the treatment of infertility. They have recently opened a crowdfunding round through the Capital Cell platform to take the drug to phase 2.